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Phospholipidsng surfactants (LS) Curosurf or Survanta from aqueous suspension to the air–
water interface progresses from multi-bilayer aggregates through multilayer ﬁlms to a coexistence between
multilayer and monolayer domains. Exposure to environmental tobacco smoke (ETS) alters this progression
as shown by Langmuir isotherms, ﬂuorescence microscopy and atomic force microscopy (AFM). After 12 h of
LS exposure to ETS, AFM images of Langmuir–Blodgett deposited ﬁlms show that ETS reduces the amount of
material near the interface and alters how surfactant is removed from the interface during compression. For
Curosurf, ETS prevents reﬁning of the ﬁlm composition during cycling; this leads to higher minimum surface
tensions. ETS also changes the morphology of the Curosurf ﬁlm by reducing the size of condensed phase
domains from 8–12 μm to ∼2 μm, suggesting a decrease in the line tension between the domains. The
minimum surface tension and morphology of the Survanta ﬁlm are less impacted by ETS exposure, although
the amount of material associated with the ﬁlm is reduced in a similar way to Curosurf. Fluorescence and
mass spectra of Survanta dispersions containing native bovine SP-B treated with ETS indicate the oxidative
degradation of protein aromatic amino acid residue side chains. Native bovine SP-C isolated from ETS
exposed Survanta had changes in molecular mass consistent with deacylation of the lipoprotein. Fourier
Transform Infrared Spectroscopy (FTIR) characterization of the hydrophobic proteins from ETS treated
Survanta dispersions show signiﬁcant changes in the conformation of SP-B and SP-C that correlate with the
altered surface activity and morphology of the lipid–protein ﬁlm.
© 2008 Elsevier B.V. All rights reserved.1. Introduction
Environmental tobacco smoke (ETS) is the smoke inhaled by
bystanders (also called passive smokers) and is a combination of
smoke emitted from the smoldering cigarette (sidestream smoke) and
smoke exhaled by the smoker (mainstream smoke) [1,2]. ETS is
qualitatively similar in composition to mainstream smoke and
contains the same carcinogens, toxic compounds and oxidizers, albeit
at lower concentrations than those inhaled by smokers [1]. Exposure
to ETS has been causally linked to lung cancer [1,3–6] and has some
associationwith asthma in never-smoking adults [1,5]. In children, ETS
exposure has been linked to lower respiratory tract infections, asthma
induction and exacerbation, and chronic respiratory symptoms such
as wheezing and coughing [1,5,7,8]. However, recognizing the
negative effects of ETS in large populations does not explain the
origin of these effects in individuals, or the effects at the molecular
scale. This limits the interventions to control or reverse ETS exposure.1 805 893 4731.
asadzinski).
ll rights reserved.Regardless of other mechanisms of action, ETS must interact with
the epithelial lining ﬂuid (ELF), the ﬂuid layer which lines the lungs
and contains antioxidants and lung surfactant (LS) [9]. The oxidants in
ETS can react to form even more reactive agents or degrade or
inactivate the components of the ELF. Since the ELF is thinner in the
lower airways and alveoli and contains a lower concentration of
antioxidants than the upper airways, damage from inhaled oxidants
such as ETS likely occurs in the alveoli and lower airways with LS being
especially vulnerable [9].
LS is a mixture of lipids and four lung speciﬁc proteins (SP-A, B, C,
and D) that lines the ELF in the interior of the lung alveoli (and to a
lesser extent in the bronchi and bronchioles) and acts to lower
interfacial tension [10,11]. A low surface tension in the lungs,
especially on expiration, leads to a negligible work of breathing and
uniform lung inﬂation [10]. The absence of LS due to prematurity
causes neonatal Respiratory Distress Syndrome (NRDS), which is
characterized by atelectasis (collapse of the alveoli) and reduced gas
exchange [10–13] and an increased effort needed to breathe. Treating
NRDS with currently available replacement clinical surfactants has
signiﬁcantly reduced neonatal mortality in developed countries [10–
12,14,15].
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Survanta is an organic extract of minced bovine lung that is
supplemented with dipalmitoylphosphatidylcholine (DPPC), palmitic
acid, and triacylglycerol. Survanta contains 80–90 wt.% phosphati-
dylcholine, of which, ∼70 wt.% is saturated DPPC [16]. About 7 wt.%
of the phospholipids are negatively charged. Survanta contains sub-
physiological levels of the amphiphilic lung surfactant speciﬁc
protein SP-B (0.04–0.13%; g/g lipid) and closer to physiological
levels of hydrophobic lung surfactant speciﬁc protein SP-C
(0.4–0.9%; g/g lipid) [16,17]. Curosurf is an extract of whole minced
porcine lung tissue puriﬁed by column chromatography that
contains 70–75 wt.% phosphatidylcholine, of which, ∼37 wt.% is
DPPC and ∼26 wt.% is unsaturated lipids [16]. It contains 0.3 % (g/g
lipid) SP-B, 0.7 % (g/g lipid) SP-C and 5 wt.% negatively charged
phospholipids [16,17]. In both preparations, cholesterol and the
hydrophilic LS proteins SP-A and SP-D are removed. In this work, we
use Survanta and Curosurf as compositionally well-deﬁned model
surfactants to determine the effects of ETS on lung surfactant ﬁlm
organization and structure and how these effects depend on
changes in surfactant composition.
The common features of native and replacement lung surfactants
suggest that a minimum, but so far, not universally accepted set of
lipid and protein components is necessary for proper lung
surfactant function [10,12,14–16,18–28]. SP-B forms multilayer
structures in conjunction with anionic unsaturated lipids [23] as
well as monolayer folds at low surface tension [29]. Model mixtures
containing SP-B [30] and unsaturated anionic lipids show a
characteristic plateau in the isotherm similar to Survanta and
Curosurf [23,24]. SP-C [31] promotes the formation of multilayer
domains in simple lipid mixtures [21,22,24,32,33] and regulates the
surface viscosity of surfactant ﬁlms [22,33]. A balance between
saturated lipids that form semi-crystalline solid phases, and
unsaturated lipids that form disordered, liquid-like phases under
physiological conditions is also likely to be essential to proper
surfactant adsorption and low surface tensions [16,21,22,25,26,33–
36]. The synergistic nature of these lipid–protein and lipid–lipid
interactions suggests that any degradation of surfactant proteins
due to ETS exposure may result in deleterious changes in surfactant
performance [9,28,37–39]. Absolute analysis of these effects of ETS
is complicated by the lack of a generally accepted lipid and protein
formulation for either native or replacement lung surfactants; for
example, the ratio of saturated to unsaturated lipids varies widely
between clinical surfactants [16], as does the fraction of cholesterol
[14–16,28]. There are also substantial variations in the composition
of native lung surfactants measured by different methods, as well as
variations between species [10,12,30,40,41].
ETS contains oxidants, free radicals and other components that can
chemically and physically degrade LS components [1,2,9,37,39].
Oxidation of lung surfactant lipids and proteins in vivo results in
impaired surfactant function and altered surfactant composition,
though the response is oxidizer and model dependant [9]. In vitro,
oxidation by Fenton regents or hypochlorous acid of surfactant
formulations yields a decrease in unsaturated lipids (phosphatidyl-
glycerols, phosphatidylcholines) and a corresponding increase in
lysolipids (lysophosphatidylglycerols, lysophosphatidylcholines) [39].
Oxidation of SP-B leads to a decreased recognition by the anti-SP-B
antibody and can induce conversion of the tryptophan-9 (Trp9) of SP-
B to hydroxyTrp, N-formylkynurenine and kynurenine [38]. SP-C
oxidation leads to lower levels of palmitoylation [31], which can lead
to loss of the alpha-helical structure [42] as well as decreased
surfactant ﬁlm stability and compressibility [21,32,42,43]. Generally,
oxidized phospholipid or phospholipid/protein formulations result in
a larger minimum surface tension at the same amount of compression
as the control [37,39], with protein oxidation more deleterious to
surface activity than lipid oxidation. Another study of phospholipid/
protein formulations exposed to reactive oxygen species found thatthe hydroxyl radical had broad inhibitory effects on surface activity
while superoxide anion altered some ﬁlm properties but not the
minimum surface tension [44].
Previous work studying the impact of ETS on LS has focused on
compositional changes, although preliminary work has been done on
LS ﬁlm morphology and surface activity [37,45–51]. Exposure to
cigarette smoke has been shown to reduce the amount of SP-B in
bronchoalveolar lavage in rats [50] and the amount of SP-A and SP-D
in humans [46]. Maternal exposure to nicotine reduced the amount of
lung surfactant lipids present in newborn rats and altered the
expression of the surfactant proteins [45]. When exposed to cigarette
smoke in vitro, the number of type II alveolar cells producing lung
surfactant decreased [51]. However, the amount of surfactant
produced per type II cell increased leading to no change in the total
surfactant production. Bronchoalveolar lavage of rats exposed to
cigarette smoke shows a signiﬁcant decrease in saturated phospha-
tidylcholines while total phospholipid content was unchanged
yielding isotherms with decreased surface activity [48]. However, a
subsequent study with environmental cigarette smoke showed little
difference in lipid and protein content or surface activity in smoke
exposed rats or controls [49].
To determine the changes in LS organization and self-assembly
that occur after exposure to ETS, we measure surface pressure, Π,
(Π=γw−γ ; γw is the surface tension of a cleanwater interface, 72mN/
m, and γ the measured surface tension) vs. area isotherms [37] with a
Langmuir trough as an in vitromodel of the epithelial lining ﬂuid. Both
Survanta and Curosurf exposed to ETS for 12–24 h (roughly
corresponding to the turnover of lung surfactant in the alveolus
[12]) are deposited from aqueous suspension so that the surfactant
adsorbs to the air–water interface from the subphase. Adsorption from
the subphase to the air–liquid interface is more physiologically
relevant than spreading from an organic solvent and allows us to
study the effects of ETS exposure on the adsorption and self-assembly
of the ﬁlms. This spreading approach also captures in vitro that LS is
not just a simple monolayer but also has a surface associated
“reservoir” adjacent to the air–water interface that impacts LS
performance [33,52–55]. Chemical variations in the LS proteins SP-B
and SP-C in Survanta are characterized using FTIR, ﬂuorescence
emission spectroscopy, and mass spectroscopy after isolation of the
hydrophobic surfactant proteins by column chromatography, gel
electrophoresis and freeze-drying.
ETS exposure reduces the amount of material in the surface
associated reservoir, suggesting changes in the mechanisms of
surfactant adsorption and desorption for both Survanta and Curosurf.
Curosurf, which contains a higher fraction of unsaturated lipids and
proteins (especially SP-B), is more adversely affected; isotherms show
that ETS prevents reﬁning of the ﬁlm composition during cycling
leading to reduced surface activity. Fluorescence microscopy images
reveal that ETS reduces the size of condensed phase domains from
8–12 μm to ∼2 μm, suggesting an alteration in the line tension. In
contrast, the minimum surface tension and morphology of the
Survanta ﬁlm are less impacted by ETS exposure, perhaps due to the
higher content of saturated lipids in Survanta. The secondary structure
of SP-B in Survanta ﬁlms exposed to ETS changes in ways that are
consistent with a less functional conformation of the protein.
Fluorescence emission spectroscopy shows the presence of N-
formylkynurenine and kynurenine, oxidation products of tryptophan
in SP-B [38] that are conﬁrmed by mass spectra. Conformational
analysis of SP-C from ETS-exposed Survanta indicates a change in the
protein secondary structure that correlates with deacylated SP-C,
which was conﬁrmed by mass spectroscopy [56]. These changes in
SP-C limit the formation and stability of the surface-associated LS
reservoir [21,32,33,57]. ETS, like other oxidizers [9,38,39], degrades
lung surfactant performance in vitro, likely through chemical
degradation of the lung speciﬁc proteins SP-B and SP-C and
unsaturated lipids.
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2.1. Sample preparation
Curosurf was purchased from Dey Laboratories (Napa, CA) and
Survanta (Abbott Laboratories, Columbus, Ohio) was excess product
used in the UCSF nursery. ETS water was generated by a smoke
exposure system located at the UC Davis Institute of Toxicology and
Environmental Health [2]. 1RF4 reference cigarettes were burned at
22 °C and 49% relative humidity in a temperature and humidity
controlled smoking machine. An 89% mainstream-11% side-stream
smoke mixture was collected and mixed with a fresh air stream for a
mean residence time of 2min. The concentrations of carbonmonoxide,
nicotine and total suspended particulates (TSP) in the smoke mixture
were 241±6 ppm,12.0mg/m3, and 77±9mg/m3 respectively. All water
used in experiments was obtained from a Millipore Gradient System
(Billerica, MA) and had a resistivity of 18.2 MΩ/cm. A ﬁxed volume of
Millipore water was exposed to the smoke mixtures for 6 h and then
refrigerated until used in experiments. The Curosurf and Survanta
stock solutions were diluted to 2 mg/ml suspensions with Millipore
water and/or ETS-exposed water. Survanta forms multimicron,
irregularly shaped bilayer aggregates in buffered saline solutions
while Curosurf forms micron to submicron spherical multilamellar
vesicles [17], consistent with the signiﬁcantly larger fraction of
saturated lipids in Survanta. Samples in ETS-exposed water were
incubated 12–24 h under refrigeration before sample characterization
as noted. Concentrations of the spreading solutions are listed as the
equivalent TSP concentration, 0–77 mg/m3; this range was similar to
previous investigations of the effects of ETS [2,37].
To analyze the chemical effects of ETS on SP-B and SP-C, Survanta
suspended for 24 h in ETS water was carefully collected from the air–
water interface of a Langmuir trough and extracted into chloroform:
methanol 2:1 [58] and the extract partitioned overnight. The extract
was then concentrated by ﬂash evaporation. SP-B and SP-C were
isolated from this extract in a liquid chromatography column packed
with Silica C8 (J.T. Baker, Phillipsburg, NJ) pre-equilibrated with
7:1:0.4 (v:v) MeOH:CHCL3:H2O+0.1% triﬂuoroacetic acid (TFA) as an
ion pairing agent. The sample was then chromatographed with the
same aqueous-organic solvent mixture to separate SP-B, SP-C and
surfactant lipids [59]. Protein samples were then solubilized in
hexaﬂuoroisopropanol:10 mM HCl (v:v, 1:1) and twice freeze-dried
to remove acetate counterions that would interfere with infrared
analysis.
3. Methods
Isotherms were recorded at 25 °C (no signiﬁcant changes were
seen from 23–37 °C [33,37] using a custom stainless steel ribbon
trough (Nima, Coventry, England) equipped with a Wilhelmy plate to
measure surface pressure. The trough had a surface area of 130 cm2, a
subphase volume of 150 mL, and a typical compression/expansion
cycle took 15 min. The ribbon trough was used to minimize losses due
to leakage as the steel ribbon provided a continuous barrier to the
surfactant. The stated concentrations of Survanta and Curosurf
dispersions were deposited dropwise onto the saline buffer subphase
(150 mM NaCl, 2 mM CaCl2, and 0.2 mM NaHCO3, pH=7) of the
Langmuir trough at the stated total surfactant concentrations and
allowed to equilibrate 20 min before beginning cycling. Surfactant
deposited in this fashion adsorbs from the subphase to the interface as
multilayer aggregates that convert to a monolayer on contact with the
air–water interface [33,60,61].
A Nikon Optiphot optical microscope (Nikon, Tokyo, Japan) was
positioned above the trough with a 50× extra-long working distance
objective (Nikon) designed for ﬂuorescent light. Full-length movies
and individual frames were recorded directly to computer (Moviestar,
Mountain View, CA). Contrast in the images was due to segregation of1 mol% ﬂuorescent lipid Texas Red-DHPE (Invitrogen, Eugene, OR)
between the liquid expanded phase, which appears light gray in
images, and the condensed phase, which appears black in the ﬁlms
[62]. Bright white areas indicate thicknesses much greater than a
monolayer, which are usually associated with multilayered surfactant
aggregates contacting the interface or folded or collapsed regions of
the ﬁlm [29,63].
Samples for AFM imaging were prepared using a vertical
Langmuir–Blodgett deposition [64,65]. The substrate, held by twee-
zers, was put in the subphase perpendicular to the surface. 100 μL of
Survanta or Curosurf aqueous suspension, diluted to 2 mg/mL (200 μg
surfactant) by Millipore or ETS water, was deposited onto the
subphase dropwise until the surface pressure was ∼15 mN/m. The
barriers were compressed to the correct surface pressure and then the
substrate was slowly pulled through the interface while the surface
pressure was held constant. Mica substrates were cleaved with
ordinary adhesive tape immediately before use. The ﬁlm covered
mica surfaces were transferred to a modiﬁed Nanoscope III AFM
(Digital Instruments, Santa Barbara, CA) for imaging under ambient
conditions. AFM imaging was done with a 150 μm×150 μm (J) scanner
in contact mode in air at ambient temperature. Silicon nitride tips
with a spring constant of 0.12 N/m were used. Excessive force on the
sample was a concern during imaging, so samples were checked often
for deformation by imaging a smaller region (10×10 μm), then
imaging at 50×50 μm to check if the smaller region was damaged.
Under the deposition and imaging conditions used here, the
hydrophobic or air-side of the ﬁlm is facing outward from the mica
and is the surface being imaged [64,65].
Infrared spectra were recorded at 25 °C using a Bruker Vector 22™
FTIR spectrometer with a DTGS detector, averaged over 256 scans at a
gain of 4 and a resolution of 2 cm−1. Protein self-ﬁlmswere prepared by
air-drying hexaﬂouroispropanol (HFIP) solutions of thematerial onto a
50×20×2mm, 45° ATR crystal ﬁtted for the Bruker (Pike Technologies)
spectrometer [66,67]. The sample was then overlaid with HFIP to
insure saturation of the peptide with the organic solvent before
measuring the IR spectrum. The relative proportions ofα-helix,β-turn,
β-sheet, and disordered conformations of the resulting IR spectrawere
determinedby Fourier self-deconvolution for bandnarrowing and area
calculations of component peaks of the FTIR spectra using curve-ﬁtting
software supplied by Galactic Software (GRAMS/32, version 5; Galactic
Industries Corp., Salem, NH). The frequency limits for the different
structures were: α-helix (1662–1645 cm−1), β-sheet (1637–1613 and
1710–1682 cm−1), β-turns (1682–1662 cm−1), and disordered or
random (1650–1637 cm−1) [68].
Steady-state ﬂuorescence emission spectra of the aromatic
residues in the SP-B protein were made at 25 °C, in reagent ethanol,
with a Cary Eclipse Fluorescence spectrophotometer at excitation
wavelengths of 275, 325, or 365 nm and with slit widths of 0.5 nm for
excitation and emission monochrometers and a photomultiplier tube
setting of 800 V. Fifty μl of the surfactant protein sample were added
to 1 ml of reagent alcohol in a quartz sample cuvette and an emission
spectrum at the relevant wavelength was obtained to detect the
presence of tryptophan (Trp), tyrosine (Tyr), N-formylkynurenine and
kynurenine.
Changes in the mass of hydrophobic surfactant proteins from ETS
exposed samples of Survanta were determined by MALDI-TOF mass
spectrometry. SP-B and SP-C proteins were isolated by isocratic
elution using Octyl (C8) preparative liquid chromatography as
described above. The eluted protein fractions were then identiﬁed
by SDS-PAGE gel electrophoresis (10–20% Tricine Gel, Invitrogen,
Carlsbad, CA). Bands corresponding to the approximate molecular
weights of SP-B and SP-C were cut out from the gel, destained and
eluted from the gel using 80% acetonitrile–water. The eluted protein
fractions were then mixed with α-cyano-4-hydroxycinnamic acid –
3,5-dimethoxy-4-hydroxy-cinnamic acid matrix (Sigma, Saint Louis,
MO) and spotted on an Applied Biosystems V700666MALDI-TOF plate
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Applied Biosystems Voyager-DE STR MALDI-TOF mass spectrometer
(Applied Biosystems, Foster City, CA) in the linear mode with delayed
extraction and negative polarity.
4. Results
4.1. Isotherms
Fig. 1 shows typical compression–expansion isotherms for pristine
and ETS-exposed (TSP=77 mg/m3) Curosurf (300 μg) and Survanta
(200 μg) on a saline buffer subphase. The amount of surfactant was
chosen to have an initial surface pressure of 15–20mN/m after 20 min
of adsorption. The compression isotherms had a characteristic plateau
atΠ∼40 mN/m followed by a rapid surface pressure increase leading
to a second plateau, also known as the collapse plateau, atΠ∼65 mN/
m [12,33,54,55]. The length of the plateau at ∼40 mN/m is more
pronounced for the ﬁrst cycle of Curosurf and decreases with
subsequent cycles [12,33]. The hysteresis between compression and
expansion cycles is typical of clinical lung surfactant isotherms [12] as
well as most preparations of native surfactant [14,69]. Compressing
the lung surfactant ﬁlm leads to collapse at a surface pressure much in
excess of the equilibrium spreading pressures of the surfactants,
which are ∼40 mN/m for Curosurf and Survanta [70]. Expanding the
interface after monolayer collapse leads to a rapid drop in surface
pressure, which is maintained until compression is resumed. This
drop in surface pressure is well below the equilibrium spreading
pressure of the surfactant. Increasing cycles (arrow) show the length
of the collapse plateau (Π∼66) increases to about 15% of the total
trough area, reaching a steady state after four cycles. At the same time,
the length of the ﬁrst plateau, associated with unsaturated lipids, at
∼40 mN/m decreases [10,12,29,32, 33].
The isotherm of ETS-exposed Curosurf in Fig. 1b shows a similar
initial surface pressure from surfactant adsorption of Π∼15 mN/m.
However, the collapse plateau at Π∼66 mN/m has almost vanished,Fig. 1. Cyclic isotherms of pristine and ETS-exposed (TSP=77 mg/m3) commercial replacemen
characteristic shoulder at Π∼40 mN/m and a collapse plateau at Πmax∼66 mN/m. (a) 300 μ
trough area. (b) 300 μg ETS-exposed Curosurf. In contrast to (a), the fourth cycle collapse plat
ETS-exposed Survanta. In both (c) and (d), the fourth cycle collapse plateau accounts for 34%
cycles.comprising only 2% of the total trough area even after the isotherm
reaches a steady state. The length of the characteristic shoulder at
∼40 mN/m decreases with cycling in the ETS-exposed Curosurf, but
this is due to the steady movement of the break in the isotherm to
lower trough areas. Hence, there is no corresponding increase in the
length of the collapse plateau as seen in the unexposed Curosurf
(Fig. 1a). In Fig. 1a, the break in the isotherm at ∼40 mN/m occurs at a
trough area of ∼60% on each cycle, and the increase to the collapse
pressure occurs at larger trough areas with each cycle. The surface
pressure at full expansion decreases with the number of cycles for the
ETS exposed Curosurf. It requires about a 4:1 compression ratio to
reach low surface tensions after Curosurf has been exposed to ETS,
compared to the 2:1 compression ratio for the pristine Curosurf for
identical amounts of deposited Curosurf. This suggests that ETS
exposure decreases the ability of Curosurf to adsorb to the air–water
interface from the subphase [60].
Fig.1c and d show four cycles of pristine Survanta and ETS-exposed
Survanta isotherms starting from similar initial surface pressures of
Π∼20 mN/m. In Survanta (Fig. 1c), increasing cycles (arrow) show the
length of the collapse plateau reaches about 35% of the total trough
area and there is a modest decrease in the length of the characteristic
shoulder at 40 mN/m. Compared to the Curosurf ﬁlm, the changes in
the isotherm with number of cycles are more subtle in Survanta. ETS-
exposed Survanta also shows a collapse plateau, which extends over
about 35% of the total trough area, similar to Survanta on a pristine
interface, and also apparently undergoes less alteration after initial
adsorption.
4.2. Fluorescence microscopy
Fig. 2 showsﬂuorescence imagesofCurosurf andETS (TSP=77mg/m3)
exposed Curosurf at 25 °C on the second cycle. Discrete black
domains coexist in a continuous medium gray background, similar to
model lung surfactant lipid–protein mixtures and other commercial
lung surfactants [13, 60, 61]. The dark domains are condensed phasest lung surfactants on a saline buffer subphase. On compression, the isotherms exhibit a
g pristine Curosurf. The fourth cycle collapse plateau here accounts for 15% of the total
eau only accounts for 2% of the total trough area. (c) 200 μg pristine Survanta (d) 200 μg
of the total trough area. Arrows indicate increasing number of compression/expansion
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[20,25,26,35]) that exclude the bulky ﬂuorophore-labeled Texas
Red-DHPE, which cannot pack into a crystalline lattice [62]. The black
domains are circular to elliptical in shape and their diameters range
from the resolution limit of the optics (∼1 μm) to ∼12 μm.
Coexistence between condensed and liquid expanded phases is
typical for both Curosurf and Survanta monolayers and occurs at all
surface pressures from zero to collapse [22,26,29,33]. Largercondensed domains (8–12 μm) occurmore frequently in the Curosurf
images (Fig. 2a,c,e,g,i) at any given surface pressure compared to ETS-
exposed Curosurf (Fig. 2b,d,f,h,j). ETS suppresses the formation of the
larger domains yielding smaller, more monodisperse condensed
phase domains. In the ETS-exposed Curosurf at Π=20 mN/m (Fig.
2b), the average domain is approximately 2 μm, which is only slightly
larger than the resolution limit of the optics. At higher surface
pressures (Fig. 2d, 2f), it is unclear whether the dark domains are
simply smaller than the resolution of the optics or whether they
disappear entirely, leaving only a small population of 5–8 μm dark
domains in the ETS-exposed Curosurf images.
A small number of circular white domains, which indicate an
accumulation of dye, and hence, surfactant, in the subphase attached
to the monolayer [60], are also present at all surface pressures. These
bright patches are thicker than a monolayer and are parts of the
surface-associated reservoir of surfactant. Through-focus series show
that the patches are on the subphase side of the monolayer. The
concentration of these bright domains increases with higher surface
pressure in both Curosurf and ETS-exposed Curosurf.
At the collapse pressure, Π=66 mN/m (Fig. 2e), cracks and folds
(arrows) are present in Curosurf. As suggested by a recent theoretical
model, the collapse folds in Fig. 2e are roughly parallel to each other
and are perpendicular to the compression direction [63]. Several
smaller folds have coalesced into the brighter white, larger folds at the
arrows, also as suggested by this theory [63]. The monolayer collapse
determines the maximum surface pressure (minimum surface ten-
sion) that can be achieved by the ﬁlm [12,18,29,63,71]. During
collapse, material is forced from the monolayer into the surfactant
surface-associated reservoir [12,29,32,33]. These cracks and folds are
absent from the ETS-exposed Curosurf images (Fig. 2f), likely because
the compression needed to reach the collapse pressure caused a much
shorter collapse plateau (See Fig. 1b). According to the theory by
Pocivavsek et al. [63], folds grow and coalesce on continued
compression after the initial monolayer collapse; for the ETS-exposed
Curosurf, monolayer collapse was not reached until the maximum
compression possible in our trough (Fig. 1b). Upon expansion, the
folds (arrows) in the Curosurf images (Fig. 2g) appear to buckle and
undulate along their length. The folds only relax back into the
monolayer when the surface pressure drops to Π=15 mN/m (Fig. 2i),
consistent with the hysteresis in the isotherm, but well below the
equilibrium spreading pressure of 40 mN/m. During the expansion
(Fig. 2g–j), the large, black, solid phase domains are more abundant in
the Curosurf images than ETS-exposed Curosurf, consistent with the
retention of the saturated lipids in the ﬁlm on cycling.
Fig. 3 shows ﬂuorescence images of Survanta and ETS-exposed
Survanta at 25 °C on the second cycle. In contrast to Curosurf, phase
separation between themottled bright and dark regions in Survanta is
more fractal in appearance and the individual domains are smaller.
Survanta has a larger percentage of saturated lipids than Curosurf [16]
and a signiﬁcantly larger fraction of black, condensed phase is present
at all surface pressures. However, there is some fraction of lighter gray,
liquid expanded phase that remains up to the collapse pressure. At
Π=20 mN/m andΠ=40 mN/m (Fig. 3a–d), the images show the black
condensed phase forms a continuous network surrounding the lighter
liquid expanded phase; the opposite of what happens for CurosurfFig. 2. Fluorescence images of 300mgpristine Curosurf and ETS-exposed (TSP=77mg/m3)
Curosurf doped with 1% mol Texas Red-DHPE. Images are 171 μm×171 μm and were
acquired on the second cycle. Discrete circular condensed domains (dark) coexist with a
continuous liquid expanded phase (light gray). (a) Curosurf and (b) ETS-exposed Curosurf
on a saline buffered subphase at Π=20 mN/m during compression. (c) Curosurf and (d)
ETS-exposed Curosurf at Π=40 mN/m during compression. (e) Curosurf and (f)
ETS-exposed Curosurf at the collapse plateau,Π=66 mN/m during compression. Arrows
indicate cracks and folds in the monolayer due to collapse which are only seen in the
Curosurf ﬁlm. (g) Curosurf and (h) ETS-exposed Curosurf at Π=40 mN/m during
expansion. (i) Curosurf and (j) ETS-exposed Curosurf at Π=15 mN/m during expansion.
Generally, ETS exposure reduces the concentration of large condensed domains (8–12 μm)
in favor of smaller ones (∼2 μm).
Fig. 3. Fluorescence images of 200 μg pristine Survanta and ETS-exposed (TSP=77 mg/
m3) Survanta dopedwith 1%mol Texas Red-DHPE. Images are 171 μm×171 μmandwere
acquired on the second cycle. The darker condensed phase forms a continuous network
surrounding the lighter liquid expanded phase. (a) Survanta and (b) ETS-exposed
Survanta a saline buffered subphase at Π=20 mN/m during compression. (c) Survanta
and (d) ETS-exposed Survanta atΠ=40 mN/m during compression. (e) Survanta and (f)
ETS-exposed Survanta at the collapse plateau, Π=67 mN/m, during compression.
Arrows indicate cracks and folds in the monolayer due to collapse. (g) Survanta and (h)
ETS-exposed Survanta at Π=40 mN/m during expansion. (i) Survanta and (j) ETS-
exposed Survanta atΠ=10 mN/m during expansion. ETS exposure has less effect on the
morphology of the Survanta ﬁlm than on Curosurf ﬁlms.
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fraction of the lighter gray, liquid expanded phase (Fig. 3a, c) although
the size of the liquid expanded domains are similar. At the collapse
pressure, Π=67 (Fig. 3e, f), cracks and folds (arrows) are present in
both the Survanta and ETS-exposed Survanta, consistent with the long
collapse plateaus shown in the isotherms (Fig. 1c, d). These cracks and
folds remain connected to the interfacial ﬁlm and provide a store-
house for surfactant removed from the interface during ﬁlm collapse.
Upon expansion, the cracks and folds (arrows) in both samples (Fig.
2g–j) reincorporate into the monolayer only after it achieves a surface
pressure ofΠ=10, which, as observed for Curosurf, is the likely cause
of the hysteresis in the isotherm (Fig. 1c, d). During expansion, both
samples display similar mottled bright and dark texture.
ETS exposure has a smaller effect on the morphology or
mechanical properties of the Survanta ﬁlm compared to Curosurf.
Previous work has shown that a high collapse pressure requires a
threshold fraction of around 70% of the solid or LC phase [72]. The
saturated lipid fraction of Survanta, even after ETS exposure, is likely
high enough to provide this necessary threshold fraction of LC phase
and the collapse pressure is not greatly affected by ETS exposure.
However, the lower fraction of saturated lipids in Curosurf [16] may
not be sufﬁcient to achieve the threshold fraction of LC phase after
ETS-exposure as ﬁlm reﬁnement appears to be compromised. In
addition, Survanta has minimal levels of SP-B, so the degradation in
function that likely accompanies oxidation of this protein will have a
small effect.
4.3. Atomic force microscopy images
To obtain higher-resolution information regarding the interfacial
ﬁlms and a quantitative estimation of the domain sizes and ﬁlm
thickness, pristine and ETS-exposed ﬁlms of Curosurf and Survanta
were imaged by AFM after Langmuir–Blodgett deposition at various
surface pressures [32,54,55,64,65,73]. During the transfer, material
located near the air–water interface can be trapped between the mica
substrate and the monolayer. Therefore, AFM can reveal the three-
dimensional structure of the surface associated reservoir [53], in
addition to the structure of the monolayer [22,33]. Although this
complicates interpretation, AFM is the only tool that can map the
three-dimensional ﬁlm morphology, as many of the features seen in
AFM are below the resolution of optical imaging techniques.
In general, ﬁlms spread from an aqueous suspension are not a
simple monolayer [33,54,55] and are quite different than AFM images
of lipid or lipid/protein ﬁlms spread from solvent [21,24,32,64,74]. Not
all of the surfactant added to the trough necessarily adsorbs to the
interface; the amount of material spread is ∼15 times that necessary
to form a single monolayer capable of reaching the collapse plateau
upon trough compression. While some of this material never reaches
the interface, surfactant ﬁlms spread from aqueous suspension can
have coexisting monolayer and multilayer domains [33,54,55], along
with multibilayer aggregates attached to the interface [60]. Quanti-
tative Brewster angle microscopy has also shown 12-nm-thick ﬁlms
adsorbing at the air–water interface from lavage ﬂuids deposited in
the subphase [75].
Representative AFM images of Curosurf and ETS-exposed Curosurf
at medium (Π=40 mN/m) and high (Π=60 mN/m) surface pressures
of the second compression isotherm are shown in Fig. 4. At 40 mN/m,
low-resolution images (50 μm×50 μm) of Curosurf (Fig. 4a) show a
bright, yellow network with discrete, dark brown circular and
elliptical domains similar in general appearance to the ﬂuorescence
images in the Fig. 2. In AFM images, bright means higher or thicker,
and dark means thinner, as is quantiﬁed in the height traces in the
third column. From the correspondence between the ﬂuorescence and
AFM images, the bright, continuous phase in FM and AFM images is
the liquid expanded phase (lighter gray in Fig. 2), whereas the discrete
dark domains in both FM and AFM images are condensed phase
Fig. 4. Atomic force microscopy images of pristine Curosurf and ETS-exposed Curosurf transferred onto mica substrates by conventional Langmuir–Blodgett deposition. The low
resolution images (left column) are 50×50 μm, and the high resolution images (right column) are 10×10 μm sections taken from the low-resolution images. The height trace in the
third column corresponds to the black line on each high-resolution image. The brightness in the image increases with the height relative to the mica substrate. Images at 40 mN/m of
Curosurf at (a) low and (a') high resolution and ETS-exposed Curosurf at (b) low and (b') high resolution. Discrete dark brown circular domains up to 10–15 μmwide in Curosurf (a,a')
and 0.2–1 μmwide ETS-exposed Curosurf (b,b') exist in a bright yellow network. The height traces indicate a greater thickness of the bright yellow liquid expanded phase in Curosurf
(∼126 nm) vs. ETS-exposed Curosurf (∼14 nm) indicates a larger surface associated “reservoir”which is trapped underneath the monolayer during LB deposition. Images at 60 mN/m
of Curosurf at (c) low and (c') high resolution and ETS-exposed Curosurf at (d) low and (d') high resolution. Both Curosurf (c) and ETS-exposed Curosurf (d) show a non-uniform liquid
expanded phase with discrete raised domains (0.3–1.3 μmwide and ∼110–140 nm high) where material that has been removed from the interface is held in the surface associated
reservoir. The linescans indicate a greater concentration of raised domains in Curosurf (c') demonstrating that ETS exposure (d') alters the ways that material is removed from the
interface.
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continuous, and the height trace of Fig. 4a' shows that the LE phase is
much thicker than the condensed domains, suggesting that the
surface associated reservoir is predominantly associated with the
liquid expanded phase. Much of the SP-B and SP-C is located in the
liquid expanded phase, and hence associated with the unsaturated
and anionic lipids [21,23,24,32]. If the proteins are involved in
adsorption or stabilization of multilayer reservoirs, it is reasonablefor the liquid expanded phase to be the most likely location for
adsorption and desorption (squeeze-out) from the ﬁlm [21,24,32].
While themajority of the dark domains in the Curosurf at 40mN/m
images (Fig. 4a,a') are between 0.3–1.5 μm wide, the low-resolution
image also shows extended dark domains with a diameters of 8–
15 μm. The extended dark domains in the AFM correlate well with the
large dark domains in the ﬂuorescence images in Fig. 2c. The smaller
dark domains are just visible in the ﬂuorescence images in Fig. 2. The
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∼126 nm thicker than the condensed phase; this corresponds to 20 or
more layers in close association with the interface. The LE/LC phase
borders are decorated with micron sized domains ∼60 nm thicker
than the liquid expanded phase, which likely corresponds to Curosurf
bilayer aggregates that have not yet spread into the ﬁlm and roughly
correspond to the bright spots in the ﬂuorescence images in Fig. 2.
These aggregates are not displaced by motions of the AFM tip,
suggesting that the aggregates are connected to the interfacial ﬁlm.
AFM images of ETS-exposed Curosurf at 40 mN/m (Fig. 4b,b') are
qualitatively similar, with a continuous bright yellow LE phase withFig. 5. Atomic force microscopy images of pristine Survanta and ETS-exposed Survanta tran
resolution images (left column) are 50×50 μm, and the high resolution images (right column
third column corresponds to the black line on each high-resolution image. The brightness in t
Survanta at (a) low and (a') high resolution and ETS-exposed Survanta at (b) low and (b') h
bright yellow fractal domains, ETS-exposed Survanta shows a greater percentage bright liquid
the condensed phase versus only∼10 nm thicker in the ETS-exposed Survanta. Images at 60m
and (b') high resolution. Both sets of images are dominated by discrete circular raised domain
less material is stored near the interface in ETS-exposed Survanta.discrete, dark brown LC phase domains. However, as in Fig. 2, there are
signiﬁcantly fewer large LC phase domains after ETS exposure, there
are only the smaller LC domains. The LC phase domains after ETS
exposure are (Fig. 4b') relatively monodisperse with a range of 0.2–
1 μm, consistent with the ﬂuorescence image in Fig. 2d, which show
small, resolution limited black spots. As expected from Fig. 2, few
extended dark domains are observed in Fig. 4a'. It appears that ETS
exposure prevents the coalescence of the LC domains, suggesting that
the line tension between the LC and LE phases decreases [76]. A
second major difference due to ETS exposure is revealed in the height
trace of Fig. 4b' that shows the LE phase is only ∼14 nm thicker thansferred onto mica substrates by conventional Langmuir–Blodgett deposition. The low
) are 10×10 μm sections taken from the low-resolution images. The height trace in the
he image increases with the height relative to the mica substrate. Images at 40 mN/m of
igh resolution. While Survanta shows a continuous dark brown network with discrete
expanded phase. The bright liquid expanded region in Survanta is ∼37 nm thicker than
N/m of Survanta at (a) low and (a') high resolution and ETS-exposed Survanta at (b) low
s, but the domains are higher and cover a greater area fraction in Survanta indicating that
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Curosurf aggregates. These images indicate that less surfactant is
being stored in the surface associated reservoir near the monolayer in
ETS-exposed Curosurf.
Images of Curosurf at 60 mN/m (Fig. 4c,c') show that the LE
domains of the ﬁlm have a patchier, spotted morphology at higher
surface pressures. The dark LC domains are more numerous and are
∼10 μmwide, similar to their size and appearance at 40 mN/m. These
domains also correspond with the condensed phase in the ﬂuores-
cence images (Fig. 3e) which are ∼10 μm in diameter. The smaller LC
domains visible in Figs. 4a, a' appear to have coalesced into the larger
LC domains. High resolution images (Fig. 4c') show that the formerly
continuous liquid expanded ﬁlm surrounding the dark patches
appears to have broken up into small bright, raised domains
∼0.3 μm wide and ∼116 nm thicker than the dark domains. This
may mean that the LE phase lipids are converting into more
spheroidal bilayer aggregates that might facilitate transport out of
the interfacial reservoir [29].
Images of ETS-exposed Curosurf at 60 mN/m (Fig. 4d,d') also show
that the continuous LE phase appears more patchy, with similar
spheroidal aggregate structures up to 1.3 μm wide and ∼140 nm
higher than the background. Fig. 4d' show that there are fewer, but
larger diameter bright spots in the ETS-exposed Curosurf compared to
the pristine Curosurf (Fig. 4c') and the coverage is not as uniform. In
contrast to pristine Curosurf (Fig. 4c), there are no large LC domains in
the ETS-exposed Curosurf, consistent with the ﬂuorescence images
(Fig. 2f). ETS exposure (Fig. 4d') apparently eliminates the coalescence
of the LC domains as well as altering theways thatmaterial is removed
from the interface. This alteration of the surface associated reservoir
due to ETS-exposure may reduce re-adsorption, leading to less
material at the interface, and the changes in the isotherms on
repeated cycling as seen in Fig. 1a–b.
At the 40 mN/m, images of Survanta (Fig. 5a) show a continuous
dark network with discrete bright, irregularly shaped domains 4–
12 μm wide, similar to the morphology of the ﬂuorescence image in
Fig. 3c. In contrast to Curosurf (Fig. 4a), the LC phase is the continuous
phase in Survanta, and constitutes a larger area fraction than the
thicker LE phase, as expected from the greater fraction of saturated
lipids in Survanta [16]. The height trace of Fig. 5a' shows that the LE
phase domains are ∼37 nm thicker than the LC phase regions. In both
Survanta and Curosurf, LE phase forms the surface associated
reservoir, which is trapped beneath the monolayer during LB
deposition. ETS-exposed Survanta (Fig. 5b,b') shows the opposite
contrast with interconnected dark domains coexisting within bright
interconnected network at 40 mN/m. The bright LE regions make up a
greater fraction of the image (Fig. 5b') compared to the pristineFig. 6. Stack plots of FTIR spectra of the amide I spectral region of the control and Smoke
hexaﬂuoroisopropanol (HFIP) and allowed to air dry. The ﬁlm was then overlaid with HFIPSurvanta (Fig. 5a'). This is consistent with the ﬂuorescence images of
ETS-exposed Survanta (Fig. 3d). However, the height trace of Fig. 5b'
reveals that the LE phase is only ∼10 nm thicker than the LC phase,
which is signiﬁcantly less than pristine Survanta (Fig. 5a') and may
explain why there is a greater fractional coverage of the LE phase in
the images. Similar to Curosurf, ETS exposure reduces the amount of
material that is being stored in the surface associated reservoir and
this appears to alter the distribution of both LC and LE phases at the
interface.
At 60 mN/m, Survanta (Fig. 5c,c') appears much more like Curosurf
at 60 mN/m (Fig. 4c,c') in that much of the image is are dominated by
small spheroidal domains 0.25–1 μmwide and 200–300 nm high on a
relatively smooth background (See height trace of Fig. 5c'). The entire
underlying ﬁlm is likely LC phase, similar to the ﬂuorescence images in
Fig. 3e. Similar to the Curosurf ﬁlm (Fig. 4c,c'), the raised domains are
likely bilayer aggregates of predominantly unsaturated lipids that
have been removed from the interface and stabilized by SP-B and/or
SP-C. In contrast to Curosurf (Fig. 4c), the raised domains in Survanta
(Fig. 5c) are distributed uniformly throughout the AFM image. The
Curosurf ﬁlm (Fig. 4c,c') retains a much higher density of these raised
domains (at high surface pressures) than does the Survanta ﬁlm, likely
due to the higher fraction of SP-B. ETS-exposed Survanta at 60 mN/m
(Fig. 5d,d') shows similar raised domains that are larger, more
irregularly shaped and less plentiful than pristine Survanta (Fig. 5c,
c'). The height trace of Fig. 5d' shows regions 0.5–2 μmwide and 150–
200 nm high. The combination of a lower area fraction of raised
domains and thinner domains indicates that less material is stored
near the interface in the ETS-exposed Survanta (Fig. 5d,d'). Similar to
Curosurf, ETS exposure alters the way material is removed from the
interface.
4.4. Conformational and chemical analysis of SP-B and SP-C from
ETS-exposed surfactants
The morphological changes of Survanta and Curosurf ﬁlms on ETS-
exposure are qualitatively similar, suggesting a decreased function of
the lung surfactant speciﬁc proteins SP-B and SP-C. Comparison of SP-
B protein isolated from ETS-exposed Survanta with that from pristine
Survanta samples indicates changes in the secondary structure of the
protein as seen by Fourier Transform Infrared (FTIR) spectroscopy
(Fig. 6A). In ETS-exposed Survanta, there was a decrease in
absorbance centered around 1656 cm−1 that is associated with the
loss of alpha helical conformations, with enhanced absorbance
centered near 1643 and 1630 cm−1, typical of disordered and beta
sheet structures. Both of these changes are consistent with oxidation
of the SP-B.treated SP-B (a) and SP-C (b). Proteins (100 μg protein) were spread as a self-ﬁlm in
solvent and spectra accumulated and processed as described in the text.
Fig. 7. Fluorescence emission spectra of Trp–Tyr SP-B (50 μg protein/mL) (a) and Fluorescence emission spectra of NFKyn (50 μg protein/mL)(b) and Kyn (50 μg protein/mL) (c)
aromatic degradation products associated with smoke treated samples. The control emission spectra were digitally subtracted from the ETS treated sample spectra to obtain the
ﬂuorescence emission spectrum of NFKyn and Kyn in the isolated protein sample. Excitation wavelength was at 275 nm for Trp and Tyr, 325 nm for NKFyn and 365 nm for Kyn.
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Survanta indicated the degradation of both tryptophan (Trp) and
tyrosine (Tyr) residues. There was a notable loss in ﬂuorescence
emission centered around 340 nm attributed to the Trp and Tyr
residues in SP-B for ETS-exposed surfactant compared with control
protein samples (Fig. 7a). Further ﬂuorescence spectroscopy of the
treated samples for aromatic amino acid oxidation revealed the
spectral signatures for the tryptophan degradation products N-
formylkynurenine (NFKyn) (Fig. 7b) and kynurenine (Kyn) (Fig. 7c)
consistent with changes in SP-B induced by oxidative chemical
treatment of SP-B by Fenton's reagent [38].
Mass spectral analysis of the dimeric bovine SP-B isolated from
ETS-exposed Survanta show elevated mass values compared with SP-
B from unexposed Survanta, which correlates with the oxidation of
tryptophan (Trp) and tyrosine (Tyr) residues observed in the
ﬂuorescence measurements. ETS-exposed SP-B had an intense mass
peak at 17,562.14 Da with a minor peak at 17,658.43 Da (Fig. 8)
comparedwith a control samplemass of 17,397.7 Da that is close to the
calculated mass of dimeric SP-B [36] (not shown). Although the
residue-speciﬁc modiﬁcations cannot be determined from the change
in mass alone, such a large alteration of mass seen in ETS-exposedFig. 8. MALDI-TOF spectrum of Bovine SP-B dimer sample eluted from SDS gel of ETS-
exposed surfactant sample. The ABI Voyager-DE STRMALDI-TOF was run in linear mode
with delayed extraction and negative polarity. The instrument had an accelerating
voltage of 2000 V, an extraction delay time of 125 ns, and a laser intensity of 1925.
Treated samples had an intense mass peak at 17,562.14 Da with a minor peak at
17,658.43 Da (this ﬁgure) compared with a control sample mass of 17,397.7 Da (not
shown) that is close to the calculated mass of dimeric SP-B [36].samples is consistent with the oxidation of all four methionines,
dihydroxytryptophan, and the formation of NFKyn similar to that
observed for other oxidative treatments of SP-B in different lipid
monolayers [38].
SP-C also showed spectral changes indicative of changes in the
secondary conformation in ETS-exposed Survanta compared with the
unexposed protein (Fig. 6b). There was a loss of absorbance centered
around 1656 cm−1 and enhanced intensity in the range from 1645 to
1620 cm−1, which is typical of a transformation from the dominant
alpha helical structure of native SP-C to random to the anti-parallel
beta sheet conformations associated with deacylated SP-C [42,43,56].
The loss of thioester linked palmitate residues from SP-C in ETS-
exposed Survanta was conﬁrmed by MALDI-TOF spectroscopy. Bovine
SP-C isolated from ETS-treated Survanta had an intense signal at
3586.97 Da (Fig. 9) indicative of completely deacylated SP-C [67].
There was also a much less intense peak at 4058.73, indicating that
only a minor population of SP-C remained fully acylated.
5. Discussion
Isotherms, FM and AFM images indicate signiﬁcant changes in the
mechanical properties, ﬁlm morphology and surface associated
reservoir [52] upon surfactant exposure to ETS-conditioned water.Fig. 9. Maldi-TOF spectrum of isolated Bovine SP-C sample eluted from SDS gel of ETS-
treated sample. SP-C isolated from the ETS-treated surfactant had an intense signal at
3586.97 Da indicative of completely deacylated SP-C [42]. There was also a much less
intense peak at 4058.73, indicating the presence of a minor population of fully acylated
SP-C.
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correspond with the observed changes in the interfacial composition.
Under normal conditions, the fraction of ﬂuid phase domains, that
contain the majority of the unsaturated lipids in the monolayer,
decreases with cycling, resulting in an increase in the fraction of solid
phase domains, which contain the majority of the saturated lipids
[21,29,32,52,54,55,77]. This leads to a stable ﬁlm that is resistant to
collapse [12,18,21,23,25,29,32,33,54,55,63,72]. Unsaturated lipids are
not capable of maintaining the high surface pressures (low surface
tensions) necessary for proper lung function under normal respira-
tion rates [18,78], so they eventually desorb or are “squeezed-out”,
likely to the reservoirs of surfactant in the multilayer patches seen in
AFM images [21–24,29,32,33,54,55,57]. The multilayer patches may
facilitate rapid exchange of reservoir material with subphase
material upon expansion and compression or assist with surfactant
adsorption from the subphase. As these raised domains are
predominantly associated with the liquid expanded phase, it is likely
that they are enriched in unsaturated lipids, and the lung surfactant
proteins SP-B and SP-C. This may be how the interfacial zone
accumulates saturated lipids; the materials that are squeezed out
come from the liquid expanded zones of the ﬁlm and are enriched in
unsaturated lipids, while new interface retains the new saturated
lipids adsorbing from the subphase. SP-C promotes the formation of
multilayer domains [21,24,32,57] and SP-B also forms 3-dimensional
structures in the LE phase of simple lipid model mixtures containing
unsaturated anionic lipids such as POPG [23]. As the monolayer
becomes enriched in saturated lipids, the ﬁlm becomes more solid-
like and elastic and can withstand higher surface pressures before
collapsing [29,63,72]. ETS exposure apparently inhibits this process
of adsorption and desorption that results in an interfacial reﬁning of
the Curosurf ﬁlm with cycling, preventing the formation of a
signiﬁcant collapse plateau.
The changes we observe depend on the surfactant composition
and are more pronounced in Curosurf compared to Survanta. Curosurf
contains a greater fraction of unsaturated lipids, 30–40wt.%wt. vs.10–
25 wt.% for Survanta, as well as higher levels of the surfactant speciﬁc
protein, SP-B (0.3% (g/g lipid) vs. 0.04–0.13 (g/g lipid)) [16,17]. As a
result, Curosurf would require a proportionally greater reﬁnement of
the ﬁlm composition than Survanta (compare Fig. 1a with c) so as to
remove sufﬁcient ﬂuid phase (and hence, unsaturated lipids) so that
the ﬁlm can maintain a high surface pressure (low surface tension).
Previous work has shown that a minimum LC phase fraction of ∼70%
correlates with a high surface pressure at ﬁlm collapse [72]. This
minimum LC fraction also leads to a divergence of the surface viscosity
for both simple lipid/protein mixtures [36] and for Curosurf and
Survanta [22,33]. This increase in the solid phase fraction alters the
mechanical properties of the ﬁlm, resulting in a collapse-resistant
ﬁlm, even under the slow compression rates in the Langmuir trough
[63,71]. It is likely that Curosurf cannot reach this minimum level of LC
phase after the inhibition of surface reﬁnement by ETS exposure.
While it may be possible for a rapidly compressed monolayer of
unsaturated, ﬂuid phase lipid to resist collapse [18,78], a minimum
fraction of solid phase appears to be necessary to generate the elastic
[54,55,63,71] and viscous [22,33,36] properties of the monolayer to
have a high collapse pressure for a wide variety of compression rates.
ETS exposure degrades both SP-B and SP-C in Survanta, conﬁrming
that these proteins are crucial components to this process. Both SP-B
and SP-C are believed to be involved in the transfer of lipid from the
monolayer to the surface associated reservoir [12,14,31–33,52,57], and
in the adsorption of surfactant from the subphase. Survanta, having a
much larger saturated lipid fraction and lower protein levels, likely is
always able to reach the minimum LC area fraction for low surface
tensions [72], even if the surface reﬁnement is inhibited by ETS
exposure. Hence, changes in the Survanta surface associated reservoir
have less impact on themechanical properties of the ﬁlm compared to
Curosurf ﬁlms.Fluorescence microscopy and AFM images conﬁrm that the
morphology of Curosurf changesmore on ETS exposure than Survanta.
In Curosurf, ﬂuorescence microscopy images show that ETS exposure
inhibits the coalescence of small, 0.5–2 μm diameter LC domains,
thereby limiting the formation of larger, 8–20 μm diameter LC
domains (8–12 μm). This suggests that ETS contains or induces the
formation of chemical species capable of lowering the line tension
between the condensed and liquid expanded domains thereby
minimizing LC domain growth [62,76,79]. AFM images show that
both Curosurf and Survanta, when adsorbed from the subphase, form
complex, multilayer ﬁlms [33] that are structurally quite different than
lipid or lipid/protein ﬁlms spread from solvent [21,24,32,74]. There is a
good correspondence between themorphology and distribution of the
LE and LC phase domains as imaged by AFM and FM, suggesting that
there is minimal rearrangement of the ﬁlms during Langmuir–
Blodgett deposition. The images at 40 mN/m demonstrate that ETS
exposure reduces the amount of material in the surface associated
reservoir; the thickness of the liquid expanded phase is reduced from
∼126 nm to ∼14 nm in Curosurf and from ∼37 nm to ∼10 nm in
Survanta. At 60 mN/m, the Curosurf and Survanta images reveal that
the liquid expanded phase is heterogeneous and consists of discrete
spheroidal aggregates likely enriched in unsaturated lipids stabilized
by SP-B and SP-C. In both Curosurf and Survanta, ETS exposure results
in fewer aggregates, indicating that less material is stored near the
interface after ETS exposure.
The AFM images conﬁrm that ETS reduces the amount of material
in the surface associated reservoir and alters the way material is
adsorbed and desorbed from the interface. While the effect on the
surface associated reservoir is similar for both surfactants, the impact
on maximum surface pressure is greater for Curosurf than Survanta
due to the greater reﬁnement required by the Curosurf ﬁlm to sustain
high surface pressures. Our results are consistent with previous work
using model lipid mixtures where ETS exposure resulted in poor
respreading after collapse, a loss of surfactant material on cycling and
lower maximum surface pressures [37]. However, for the pure lipid
systems, we did not observe any multilayer reservoir formation in
either pristine or ETS-exposed lipids, which suggests that the
reservoir is due to adsorption and desorption from the subphase.
The stability and extent of the multilayer reservoir is likely related
to the presence of SP-B and SP-C. Oxidation of the Trp and Tyr amino
acids, along with the changes in secondary structure on ETS exposure
of SP-B in Survanta suggests that a corresponding degradation in the
function of SP-B may be partially responsible for the morphological
changes we see in the ﬁlms [22,23,32,33,52,53]. Similar changes in the
hydrophobic amino acid side chains of SP-B have also been observed
due to oxidation in Fenton reagent-treated surfactant extracts of
different lipid composition than either Survanta or Curosurf [38].
These changes in the hydrophobic protein side chain chemistry
correlated with a decrease in phospholipid respreading during the
compression and expansion of the surfactant ﬁlm as well as the failure
of these ﬁlms to attain low surface tensions during compression as we
observe here.
Similarly the chemical alteration of the SP-C protein in Survanta by
deacylation has been shown to decrease the surface activity of
surfactant dispersions and enhance beta-sheet conformations at the
expense of the dominant alpha-helix [42,43,56], correlating the
changes in the chemical composition and secondary structure of the
amphipathic surfactant proteinwith alteredmorphology and function.
SP-C helps stabilizemultilayer formationdue to its hydrophobic helical
structure which can insert normal to the bilayer; the fatty acid chains
on SP-C can anchor one bilayer to another, greatly increasing the
stability of the surface-associated reservoir [21,22,32,33,57]. SP-C
primarily alters the distribution of unsaturated lipids, Flach et al. [80]
showed minimal alterations in pure DPPC ﬁlms on deacylation, while
Wang et al. [43] showed signiﬁcant changes in isotherms and
adsorption of mixed saturated and unsaturated lipids similar to
369P.C. Stenger et al. / Biochimica et Biophysica Acta 1788 (2009) 358–370those reported here. As SP-C appears to primarily affect the LE phase
that contains the unsaturated lipids, it is not surprising that ﬁlms with
no unsaturated lipids would be relatively unaltered, similar to
Survanta,whileﬁlmswithmore unsaturated lipids, similar to Curosurf,
would be altered more signiﬁcantly, as we observe. Deacylation and
loss of helical secondary structure of SP-C may be why we see such a
noticeable decrease in the amount of material trapped in the surface
associated reservoir in the Curosurf ﬁlms; there is simply less
functional SP-C to mechanically reinforce the multilayers [57].
While the impact of ETS exposure on lung surfactant lipid and
protein chemistry and morphology was assessed in this study, there
are additional effects of ETS exposure that can further compromise
lung surfactant function. Only those components of ETS that are
water-soluble can interact with the surfactant in our model system;
hence, we are probably underestimating the actual effects of ETS on
surfactant. While direct exposure of the surfactant interfacial ﬁlm to
tobacco smoke is also possible, it would lead to artifacts that would
confuse interpretation of the AFM and FM images, obscuring the
physical and chemical interactions between the lung surfactant and
water soluble compounds in ETS. Several isotherm measurements by
Subramaniam et. al have shown that exposure to tobacco smoke
(mainstream or ETS) affects the mechanical properties of lung
surfactant in agreement with our current ﬁndings using ETS-exposed
surfactants [48,49].
6. Conclusions
ETS exposure modiﬁes the chemical, mechanical and morpholo-
gical properties at the air–liquid interface of the clinical replacement
lung surfactants Curosurf and Survanta, thereby reducing their
effectiveness at lowering surface tension in vitro. AFM images of
Survanta and Curosurf show that ETS reduces the amount of material
near the interface and alters how surfactant is adsorbed and desorbed
from the interface during compression/expansion cycles. In Curosurf,
the ﬁlms cannot be sufﬁciently reﬁned to reach the minimum level of
LC phase [72], which leads to higher minimum surface tensions. These
effects are likely due to the oxidation of the surfactant speciﬁc protein
SP-B and deacylation of SP-C we observe in Survanta ﬁlms, which
inhibits the proteins' ability to promote exchange between the
surface-associated reservoir [52] and the active monolayer
[21,23,29,32,43]. ETS also changes the lateral distribution of LE and
LC domains in the Curosurf ﬁlm, reducing the line tension between the
liquid expanded and condensed phases [79]. This prevents the
coalescence of small LC domains to larger ones that may lead to
lower surface tensions [72]. In contrast, the minimum surface tension
of the Survanta ﬁlm is less impacted by ETS exposure as expected from
its smaller fraction of unsaturated lipids and surfactant proteins.
Exposure to ETS increases the work of breathing by destabilizing the
surfactant associated reservoir and reﬁning of the interfacial ﬁlm, both
of which lead to higher minimum surface tension during the
breathing cycle.
Acknowledgments
We thank Bill Taeusch for ongoing collaborations on surfactant
adsorption and Dale Uyeminami for preparing the smoke-conditioned
water. Support for this work comes from National Institute of Health
Grants HL-66410 (AJW), HL-51177 (JAZ), and ES011634 (KEP) and the
Tobacco Related Disease Research Program 14RT-0077 (JAZ, AJW) and
7RT-0118 (KEP). P.C.S. was partially supported by a NSF graduate
research fellowship.
References
[1] M. Chan-Yeung, H. Dimich-Ward, Respiratory health effects of exposure to
environmental tobacco smoke, Respirology 8 (2003) 131–139.[2] S.V. Teague, K.E. Pinkerton, M. Goldsmith, A. Gebremichael, S. Chang, R.A. Jenkins,
J.H. Moneyhun, Sidestream cigarette-smoke generation and exposure system for
environmental tobacco-smoke studies, Inhal. Toxicol. 6 (1994) 79–93.
[3] F. Adlkofer, Lung cancer due to passive smoking — a review, Int. Arch. Occup.
Environ. Health 74 (2001) 231–241.
[4] A. Dunn, L. Zeine, California Environmental Protection Agency, Sacramento, CA,
1997.
[5] C. Janson, The effect of passive smoking on respiratory health in children and
adults, Int. J. Tuberc. Lung Dis. 8 (2004) 510–516.
[6] K.C. Johnson, J.F. Hu, Y. Mao, Lifetime residential and workplace exposure to
environmental tobacco smoke and lung cancer in never-smoking women, Canada
1994–97, Int. J. Cancer 93 (2001) 902–906.
[7] M.L. Larsson, M. Frisk, J. Hallstrom, J. Kiviloog, B. Lundback, Environmental tobacco
smoke exposure during childhood is associated with increased prevalence of
asthma in adults, Chest 120 (2001) 711–717.
[8] F.D. Gilliland, Y.F. Li, J.M. Peters, Effects of maternal smoking during pregnancy and
environmental tobacco smoke on asthma and wheezing in children, Am. J. Respir.
Crit. Care Med. 163 (2001) 429–436.
[9] E. Putman, L.M.G. vanGolde, H.P. Haagsman, Toxic oxidant species and their
impact on the pulmonary surfactant system, Lung 175 (1997) 75–103.
[10] J.A. Clements, M.E. Avery, Lung surfactant and neonatal respiratory distress
syndrome, Am. J. Respir. Crit. Care Med. 157 (1998) S59–S66.
[11] M.E. Avery, Surfactant deﬁciency in hyaline membrane disease — the story of
discovery, Am. J. Respir. Crit. Care Med. 161 (2000) 1074–1075.
[12] R. Notter, Lung Surfactant: Basic Science and Clinical Applications, Marcel Dekker,
New York, 2000.
[13] J.A. Zasadzinski, J. Ding, H.E. Warriner, F. Bringezu, A.J. Waring, The physics and
physiology of lung surfactants, Curr. Opin. Colloid Interface Sci. 6 (2001)
506–513.
[14] J. Perez-Gil, Structure of pulmonary surfactant membranes and ﬁlms: the role of
proteins and lipid–protein interactions, Biochim. Biophys. Acta, (BBA)-Biomembr.
1778 (2008) 1676–1695.
[15] Y.Y. Zuo, R.A. Veldhuizen, A.W. Neumann, N.O. Peterson, F. Possmayer, Current
perspectives in pulmonary surfactant — inhibition, enhancement and evaluation,
Biochim. Biophys. Acta 1778 (2008) 1947–1977.
[16] W. Bernhard, J. Mottaghian, A. Gebert, G.A. Rau, H. von der Hardt, C.F. Poets,
Commercial versus native surfactants — surface activity, molecular components,
and the effect of calcium, Am. J. Respir. Crit. Care Med. 162 (2000) 1524–1533.
[17] A. Braun, P.C. Stenger, H.E. Warriner, J.A. Zasadzinski, K.W. Lu, H.W. Taeusch, A
freeze-fracture transmission electron microscope and small angle X-ray diffrac-
tion study of the effects of albumin, Serum and polymers on clinical lung
surfactant microstructure, Biophys. J. 93 (2007) 123–139.
[18] E.C. Smith, J.M. Crane, T.G. Laderas, S.B. Hall, Metastability of a supercompressed
ﬂuid monolayer, Biophys. J. 85 (2003) 3048–3057.
[19] F. Lhert, W. Yan, S.C. Biswas, S.B. Hall, Effects of hydrophobic surfactant proteins on
collapse of pulmonary surfactant monolayers, Biophys. J. 93 (2007) 4237–4243.
[20] K.Y.C. Lee, J. Majewski, T.L. Kuhl, P.B. Howes, K. Kjaer, M.M. Lipp, A. Waring, J.A.
Zasadzinski, G.S. Smith, Synchrotron X-ray study of lung surfactant speciﬁc
protein SP-B in lipid monolayers, Biophys. J. 81 (2001) 572–585.
[21] J.Q. Ding, D.Y. Takamoto, A. von Nahmen, M.M. Lipp, K.Y.C. Lee, A.J. Waring, J.A.
Zasadzinski, Effects of lung surfactant proteins, SP-B and SP-C, and palmitic acid
on monolayer stability, Biophys. J. 80 (2001) 2262–2272.
[22] C. Alonso, A. Waring, J.A. Zasadzinski, Keeping lung surfactant where it belongs:
protein regulation of two-dimensional viscosity, Biophys. J. 89 (2005) 266–273.
[23] J.Q. Ding, I. Doudevski, H.E. Warriner, T. Alig, J.A. Zasadzinski, Nanostructure
changes in lung surfactant monolayers induced by interactions between
palmitoyloleoylphosphatidylglycerol and surfactant protein B, Langmuir 19
(2003) 1539–1550.
[24] D.Y. Takamoto, M.M. Lipp, A. von Nahmen, K.Y.C. Lee, A.J. Waring, J.A. Zasadzinski,
Interaction of lung surfactant proteins with anionic phospholipids, Biophys. J. 81
(2001) 153–169.
[25] K.Y.C. Lee, A. Gopal, A. von Nahmen, J.A. Zasadzinski, J. Majewski, G.S. Smith, P.B.
Howes, K. Kjaer, Inﬂuence of palmitic acid and hexadecanol on the phase
transition temperature and molecular packing of dipalmitoylphosphatidyl-
choline monolayers at the air-water interface, J. Chem. Phys. 116 (2002)
774–783.
[26] C. Alonso, F. Bringezu, G. Brezesinski, A.J. Waring, J.A. Zasadzinski, Modifying calf
lung surfactant by hexadecanol, Langmuir 21 (2005) 1028–1035.
[27] I. Plasencia, K.M.W. Keough, J. Perez-Gil, Interaction of the N-terminal segment of
pulmonary surfactant protein SP-C with interfacial phospholipid ﬁlms, Biochim.
Biophys. Acta 1713 (2005) 118–128.
[28] L. Gunasekara, W.M. Schoel, S. Schürch, M.W. Amrein, A comparative study of
mechanisms of surfactant inhibition, Biochim. Biophys. Acta 1778 (2008)
433–444.
[29] M.M. Lipp, K.Y.C. Lee, D.Y. Takamoto, J.A. Zasadzinski, A.J. Waring, Coexistence of
buckled and ﬂat monolayers, Phys. Rev. Lett. 81 (1998) 1650–1653.
[30] J. Goerke, Pulmonary surfactant: functions and molecular composition, Biochim.
Biophys. Acta, Mol. Basis Dis. 1408 (1998) 79–89.
[31] J. Johansson, Structure and properties of surfactant protein C, Biochim. Biophys.
Acta, Mol. Basis Dis. 1408 (1998) 161–172.
[32] A. vonNahmen, M. Schenk, M. Sieber, M. Amrein, The structure of a model
pulmonary surfactant as revealed by scanning force microscopy, Biophys. J. 72
(1997) 463–469.
[33] C. Alonso, T. Alig, J. Yoon, F. Bringezu, H. Warriner, J.A. Zasadzinski, More than a
monolayer: relating lung surfactant structure and mechanics to composition,
Biophys. J. 87 (2004) 4188–4202.
370 P.C. Stenger et al. / Biochimica et Biophysica Acta 1788 (2009) 358–370[34] R. Veldhuizen, K. Nag, S. Orgeig, F. Possmayer, The role of lipids in pulmonary
surfactant, Biochim. Biophys. Acta, Mol. Basis Dis. 1408 (1998) 90–108.
[35] F. Bringezu, J.Q. Ding, G. Brezesinski, J.A. Zasadzinski, Changes in model lung
surfactant monolayers induced by palmitic acid, Langmuir 17 (2001) 4641–4648.
[36] J.Q. Ding, H.E. Warriner, J.A. Zasadzinski, Viscosity of two-dimensional suspen-
sions, Phys. Rev. Lett. 88 (2002) 168102.
[37] F. Bringezu, K.E. Pinkerton, J.A. Zasadzinski, Environmental tobacco smoke effects
on the primary lipids of lung surfactant, Langmuir 19 (2003) 2900–2907.
[38] D. Manzanares, K. Rodriguez-Capote, S.C. Liu, T. Haines, Y. Ramos, L. Zhao, A.
Doherty-Kirby, G. Lajoie, F. Possmayer, Modiﬁcation of tryptophan and methio-
nine residues is implicated in the oxidative inactivation of Surfactant Protein B,
Biochemistry 46 (2007) 5604–5615.
[39] K. Rodriguez-Capote, D. Manzanares, T. Haines, F. Possmayer, Reactive oxygen
species inactivation of surfactant involves structural and functional alterations to
surfactant proteins SP-B and SP-C, Biophys. J. 90 (2006) 2808–2821.
[40] O. Blanco, J. Perez-Gil, Biochemical and pharmacological differences between
preparations of exogenous natural surfactant used to treat RDS, Eur. J. Pharmacol.
568 (2007) 1–15.
[41] S. Orgeig, C.B. Daniels, The roles of cholesterol in pulmonary surfactant: insights
from comparative and evolutionary studies, Comp. Biochem. Phys. A 129 (2001)
75–89.
[42] R.A. Dluhy, S. Shanmukh, J.b. Leapard, P. Kruger, J.E. Baatz, Deacylated pulmonary
surfactant protein SP-C transforms from alpha-helical to amyloid ﬁbril structures
via a pH dependent mechanism: an infrared structural investigation, Biophys. J. 85
(2003) 2417–2429.
[43] Z. Wang, O. Gurel, J.E. Baatz, R.H. Notter, Acylation of pulmonary surfactant
protein-C is required for its optimal surface active interactions with phospholi-
pids, J. Biol. Chem. 271 (1996) 19104–19109.
[44] M.M. Lee, F.H.Y. Green, S. Schurch, S. Cheng, S.G. Bjarnason, S. Leonard,W.Wallace,
F. Possmayer, V. Vallyathan, Comparison of inhibitory effects of oxygen radicals
and calf serum protein on surfactant activity, Mol. Cell. Biochem. 259 (2004)
15–22.
[45] C.M. Chen, L.F. Wang, T.F. Yeh, Effects of maternal nicotine exposure on lung
surfactant system in rats, Pediatr. Pulmonol. 39 (2005) 97–102.
[46] Y. Honda, H. Takahashi, Y. Kuroki, T. Akino, S. Abe, Decreased contents of surfactant
proteins A and D in BAL ﬂuids of healthy smokers, Chest 109 (1996) 1006–1009.
[47] M. Robin, P. Dong, C. Hermans, A. Bernard, A.D. Bersten, I.R. Doyle, Serum levels of
CC16, SP-A and SP-B reﬂect tobacco-smoke exclosure in asymptomatic subjects,
Eur. Respir. J. 20 (2002) 1152–1161.
[48] S. Subramaniam, P. Bummer, C.G. Gairola, Biochemical and biophysical character-
ization of pulmonary surfactant in rats exposed chronically to cigarette-smoke,
Fundam. Appl. Toxicol. 27 (1995) 63–69.
[49] S. Subramaniam, S. Srinivasan, P.M. Bummer, C.G. Gairola, Perinatal sidestream
cigarette smoke exposure and the developing pulmonary surfactant system in
rats, Human Exp. Toxicol. 18 (1999) 206–211.
[50] S. Subramaniam, J.A. Whitsett, W. Hull, C.G. Gairola, Alteration of pulmonary
surfactant proteins in rats chronically exposed to cigarette smoke, Toxicol. Appl.
Pharmacol. 140 (1996) 274–280.
[51] Y. Xue, T.L. Williams, T. Li, J. Umbehr, L. Fang, W.Q. Wang, R.C. Baybutt, Type II
pneumocytes modulate surfactant production in response to cigarette smoke
constituents: restoration by vitamins A and E, Toxicol. in Vitro 19 (2005)
1061–1069.
[52] S. Schürch, F.H.Y. Green, H. Bachofen, Formation and structure of surface ﬁlms:
captive bubble surfactometry, Biochim. Biophys. Acta 1408 (1998) 180–202.
[53] S. Schürch, R. Qanbar, H. Bachofen, F. Possmayer, The surface-associated surfactant
reservoir in the alveolar lining, Biol. Neonate 67 (1995) 61–76.
[54] Y.Y. Zuo, S.M. Takayyon, E. Keaing, L. Zhao, R.A. Veldhuizen, N.O. Peterson, M.W.
Amrein, F. Possmayer, Atomic force microscopy studies of functional and
dysfunctional pulmonary surfactant ﬁlms, II. Albumin-inhibited surfactant ﬁlms
and the effects of SP-A, Biophys. J. 95 (2008) 2779–2791.
[55] Y.Y. Zuo, S.M. Takayyon, E. Keaing, L. Zhao, R.A. Veldhuizen, N.O. Peterson, M.W.
Amrein, F. Possmayer, Atomic force microscopy studies of functional and
dysfunctional pulmonary surfactant ﬁlms, I. Micro and nanostructures of
functional pulmonary surfactant ﬁlms and the effect of SP-A, Biophys. J. 94
(2008) 3459–3564.[56] G. Vandenbussche, A. Clercx, T. Curstedt, J. Johannsson, H. Jornvall, J.-M.
Ruysschaert, Structure and orientation of the surfactant associated protein C in
a lipid bilayer, Eur. J. Biochem. 203 (1992) 201–209.
[57] Z. Leonenko, M. Rodenstein, J. Dohner, L.M. Eng, M.W. Amrein, Electrical surface
potential of pulmonary surfactant, Langmuir 21 (2006) 10135–10139.
[58] J. Folch, M. Lees, G.H. Sloane-Stanley, A simple method for the isolation and
puriﬁcation of total lipids from animal tissues, J. Biol. Chem. 226 (1957) 497–505.
[59] J.E. Baatz, Y. Zou, J.T. Cox, Z. Wang, R.H. Notter, High-yield puriﬁcation of lung
surfactant protein SP-B and SP-C and the effects of surface activity, Protein Expr.
Purif. 23 (2001) 180–190.
[60] P.C. Stenger, J.A. Zasadzinski, Enhanced surfactant adsorption via polymer
depletion forces: a simple model for reversing surfactant inhibition in acute
respiratory distress syndrome, Biophys. J. 92 (2007) 3–9.
[61] P.S. Stenger, S.G Isbell and J.A. Zasadzinski, Molecular weight dependence of the
depletion attraction and its effects on the competitive adsorption of lung surfactant.
Biochim. Biophys. Acta DOI information: 10.1016/j.bbamem.2008.03.019 (2008).
[62] H.M. McConnell, Structures and transitions in lipid monolayers at the air–water-
interface, Annu. Rev. Phys. chem. 42 (1991) 171–195.
[63] L. Pocivavsek, R. Dellsy, A. Kern, S. Johnson, B. Lin, K.Y.C. Lee, E. Cerda, Stress and
fold localization in thin elastic membranes, Science 320 (2008) 912–916.
[64] J. Garnaes, D.K. Schwartz, R. Viswanathan, J. Zasadzinski, Domain boundaries and
buckling superstructures in Langmuir–Blodgett ﬁlms, Nature 357 (1992) 54–57.
[65] D.Y. Takamoto, E. Aydil, J.A. Zasadzinski, A. Ivanova, D.K. Schwartz, T. Yang, P.
Cremer, Stable ordering in Langmuir–Blodgett ﬁlms, Science 293 (2001)
1292–1295.
[66] L.M. Gordon, K.Y.C. Lee, J.A. Zasadzinski, F.J. Walther, M.A. Sherman, A.J. Waring,
Conformational mapping of the N-terminal segment of surfactant protein B in
lipid using 13C-enhanced Fourier transform infrared spectroscopy, J. Peptide Res.
55 (2000) 330–347.
[67] L.M. Gordon, P.W. Mobley, R. Pilpa, M.A. Sherman, A.J. Waring, Conformational
mapping of the N-terminal peptide of HIV-1 gp41 in membrane environments
using 13C-enhanced Fourier transform infrared spectroscopy, Biochim. Biophys.
Acta 1559 (2002) 96–120.
[68] D.M. Byler, H. Susi, Examination of the secondary structure of proteins by
deconvoluted FTIR, Biopolymers 25 (1986) 465–487.
[69] J.A. Clements, Surface tension of lung extracts, Proc. Soc. Exp. Biol. Med. 95 (1957)
170–172.
[70] H.W. Taeusch, J.B. de la Serna, J. Perez-Gil, C. Alonso, J.A. Zasadzinski, Inactivation
of pulmonary surfactant due to serum-inhibited adsorption and reversal by
hydrophilic polymers: Experimental, Biophys. J. 89 (2005) 1769–1779.
[71] W. Lu, C.M. Knobler, R.F. Bruinsma, M. Twardos, M. Dennin, Folding Langmuir
monolayers, Phys. Rev. Lett. 89 (2002) 146107.
[72] A. Gopal, K.Y.C. Lee, Headgroup percolation and collapse of condensed Langmuir
monolayers, J. Phys. Chem. B 110 (2006) 22079–22087.
[73] J.A. Zasadzinski, R. Viswanathan, L. Madsen, J. Garnaes, D.K. Schwartz, Langmuir–
Blodgett Films, Science 263 (1994) 1726–1733.
[74] A. Cruz, L. Vazquez, M. Velez, J. Perez-Gil, Effect of pulmonary surfactant protein
SP-B on the micro- and nanostructure of phospholipid ﬁlms, Biophys. J. 86 (2004)
308–320.
[75] K. Winsel, D. Honig, K. Lunkenheimer, K. Geggel, C. Witt, Quantitative Brewster
angle microscopy of the surface ﬁlm of human broncho-alveolar lavage ﬂuid, Eur.
Biophys. J. Biophys. Lett. 32 (2003) 544–552.
[76] M. Seul, D. Andelman, Domain shapes and patterns: the phenomenology of
modulated phases, Science 267 (1995) 476–483.
[77] K. Nag, J. Perez-Gil, M.L. Ruano, L.A. Worthman, J. Stewart, C. Casals, K.M.W.
Keough, Phase transitions in ﬁlms of lung surfactant at the air–water interface,
Biophys. J. 74 (1998) 2983–2995.
[78] W. Yan, S.C. Biswas, T.G. Laderas, S.B. Hall, The melting of pulmonary surfactant
monolayers, J. Appl. Physiol. 102 (2007) 1739–1745.
[79] S.L. Keller, W.H.I. Pitcher, W.H. Huestis, H.M. McConnell, Red blood cell lipids form
immisible liquids, Phys. Rev. Lett. 81 (1998) 5019–5022.
[80] C.R. Flach, A. Gericke, K.M. Keough, R. Mendelsohn, Palmitoylation of lung
surfactant protein SP-C alters surface thermodynamics, but not protein secon-
dary structure or orientation in DPPC ﬁlms, Biochim. Biophys. Acta 1416 (1999)
11–20.
